Impacts of a Brazilian pharmaceutical program on the health of chronic patients.
Almeida, Aléssio Tony Cavalcanti de; Sá, Edvaldo Batista de; Vieira, Fabiola Sulpino; Benevides, Rodrigo Pucci de Sá E.
Rev Saude Publica
; 53: 20, 2019 Jan 31.
Artigo em Inglês, Português | MEDLINE | ID: mdl-30726501
Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy.
Linezolid for drug-resistant pulmonary tuberculosis.
Corticosteroids for dengue infection.
Growth factors for angiogenesis in peripheral arterial disease.
In the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort study.
Corticosteroids as adjunctive therapy in the treatment of influenza.
Prostanoids for critical limb ischaemia.
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.
Vasopressors for hypotensive shock.